1、(Stock Code 股份代號:630)(Incorporated in Bermuda with limited liability)(於百慕達註冊成立之有限公司)AMCO UNITED HOLDING LIMITED2022 INTERIM REPORT 中 期 報 告*For identification purposes only 僅供識別1Contents目錄 AMCO UNITED HOLDING LIMITEDInterim Report 2022雋泰控股有限公司2022 中期報告Management Discussion and Analysis管理層討論及分析2Corpor
2、ate Governance and Other Information企業管治及其他資料13Interim Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income簡明綜合中期損益及其他全面收益表21Interim Condensed Consolidated Statement of Financial Position簡明綜合中期財務狀況表22Interim Condensed Consolidated Statement of Changes in Equity簡明綜合中期權益變動
3、表23Interim Condensed Consolidated Statement of Cash Flows簡明綜合中期現金流量表24Notes to the Interim Condensed Consolidated Financial Statements簡明綜合中期財務報表附註252Management Discussion and Analysis管理層討論及分析 AMCO UNITED HOLDING LIMITEDInterim Report 2022雋泰控股有限公司2022 中期報告業績、業務回顧及前景業績截至二零二二年六月三十日止六個月,雋泰控股有限公司(本公司)及其附
4、屬公司(統稱為 本集團)之主要業務為(i)製造及銷售醫療設備產品(醫療產品業務);(ii)製造及銷售塑膠模具產品(塑膠產品業務);(iii)提供樓宇建造、樓宇維修及改善工程、項目管理、裝修及裝飾工程方面之建造服務(樓宇承包工程業務);(iv)提供放貸(放貸業務);及(v)證券投資(證券投資)。於回顧期間,本集團之收入為25,000,000港元,較去年同期之29,800,000港元減少4,800,000港元或16.1%。該減少乃主要由於來自醫療產品業務及樓宇承包工程業務之收入減少所致。本集團毛利為7,100,000港元,較去年同期之9,100,000港元減少2,000,000港元或22.0%。毛
5、利率略微減少2.2個百分點至28.3%(二零二一年六月三十日:30.5%)。其他虧損(扣除其他收入及其他收益)於回顧期間錄得虧損10,600,000港元,而二零二一年同期為收益11,400,000港元。本期間計入證券投資產生之持作買賣投資未變現公允價值收益(虧損)之金額較去年同期轉盈為虧。RESULTS,BUSINESS REVIEW AND PROSPECTSResultsFor the six months ended 30 June 2022,AMCO United Holding Limited(the“Company”)and its subsidiaries(collectivel
6、y referred to as the“Group”)are principally engaged in(i)manufacture and sale of medical devices products(“Medical Products Business”);(ii)manufacture and sale of plastic moulding products(“Plastic Products Business”);(iii)provision of construction services in building construction,building maintena